Gov. Ned Lamont and Health Commissioner Manisha Juthani have urged adult residents to get inoculated ahead of the holidays.
The deal is part of a larger, $26 billion settlement the companies negotiated with state and local governments.
Nearly a third of all wasted COVID vaccine doses in CT were lost since the end of May.
Dozens of clinics will begin taking walk-ups on Tuesday
Gov. Ned Lamont and other governors expressed dismay to the White House over pausing the Johnson & Johnson vaccine.
Officials ‘paused’ administration of the vaccine on Tuesday
Manufacturing problems will delay thousands of Johnson & Johnson COVID-19 vaccines from reaching Connecticut in the coming weeks.
Officials credit Connecticut’s success in vaccinating older residents for keeping the COVID-19 death rate low as cases rise.
The proposal calls for a three-stage distribution plan, but complex logistics remain unresolved.
While Blacks and Latinos are hardest hit by the coronavirus, they are wary of participating in vaccine trials.
Dozens of drug companies, and others blamed for the opioid crisis may follow Purdue Pharma’s lead and try to settle claims against them.
Updated at 10:15 a.m. with industry comment
WASHINGTON — Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of suits by states, counties and cities alleging it is partly to blame for the nation’s opioid epidemic. The lawsuits are all different and some include other pharmaceutical companies and pharmacies as defendants. But Purdue is nearly always a main defendant.